Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants
Chemical Research in Toxicology · 2024
DOI: 10.1021/acs.chemrestox.4c00298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Yun-Shan Zhong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Toxicology and Pharmacology, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. Chi…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Dextromethorphan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Cytochrome P450 2D6 (CYP2D6) exhibits rich genetic polymorphism, and functional changes caused by variations are the key reasons for differences in substrate drug systemic exposure. Discovering novel variants and defining their enzymatic kinetic characteristics can contribute to the personalized application of drugs. In this study, a data chain of variant-function-structure was established through population-based sequencing, baculovirus insect cell expression, in vitro enzymatic incubation, and ultrahigh performance liquid chromatography tandem mass spectrometry. Results revealed nine novel missense mutations in the exonic regions. After the corresponding microsomes were obtained, the kinetics of the variants were investigated using dextromethorphan as a probe substrate. It was found that the activities of CYP2D6.2, 10, 17, 35, 65, R28G, T76M, and E215K were significantly reduced, while D301V almost led to loss of enzyme function. Additionally, the relative clearance rate of R25Q was significantly increased. From the molecular structure perspective, the mutation sites are distributed outside the dextromethorphan binding pocket, suggesting that they primarily influence CYP2D6 activity via allosteric modulation. These research findings provide fundamental data for the precise application of CYP2D6 substrate drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Toxicology and Pharmacology, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China.
- The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beij…
- Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100005, P.R. China.
ORCID-Profile: Jian-Chang Qian
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zhong, Y. S., Kong, Q. H., Wang, J., Ye, F., Li, X. Y., Zhang, L. Q., Dai, D. P., Hu, G. X., Cai, J. P., Qian, J. C., & Ji, F. S. (2024). Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00298
Vancouver
Zhong YS, Kong QH, Wang J, Ye F, Li XY, Zhang LQ, et al. Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.4c00298
BibTeX
@article{Zhong2024,
author = {Zhong, Yun-Shan and Kong, Qi-Hui and Wang, Jing and Ye, Feng and Li, Xin-Yue and Zhang, Li-Qun and Dai, Da-Peng and Hu, Guo-Xin and Cai, Jian-Ping and Qian, Jian-Chang and Ji, Fu-Sui},
title = {Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants},
journal = {Chemical Research in Toxicology},
year = {2024},
doi = {10.1021/acs.chemrestox.4c00298}
}
EUVIMED